65,437 trials
Neuroendocrine Carcinoma of the Lung and Thymus
Primary: Percentage of Participants Progression-free at 9 Months Based on Response Evaluation Criteria In Solid Tumors v1.1 (RECIST v1.1) — 0; 0; 0; 2.4 percentage of participants
Obstructive Sleep Apnea (OSA)
Primary: Number of Subjects in Which Electroencephalogram (EEG) Signals is Collected — 47 Participants
Accuracy of Measurement of Respiration Rate
Primary: Respiration Rate Accuracy — 0.4 breaths per minute
Healthy
Primary: Safety and Tolerability Assessments by Vital Signs — 3; 3; 6; 6 Participants
Menopause
Primary: Percent Change in BOLD Signal — -.43; .20 percentage of BOLD signal changes
Postdural Puncture Headache · Post-Lumbar Puncture Headache · Cerebrospinal Fluid Leaks
Primary: Participants Who Report Post Dural Puncture Headaches — 21; 27 Participants — p=.877
Obesity
Primary: Post-prandial Glucose Concentrations — 4.9; 4.8; 4.9; 5.01 mmol/l
Presbyopia
Primary: Binocular Contact Lens-Corrected Visual Performance Under Standard High Contrast Bright — -0.12; -0.12; -0.06; -0.06 logMAR
Glabellar Lines
Primary: Incidence of Adverse Events (AEs) — 374 Participants
Viral Respiratory Infection
Primary: Duration of Influenza/ARVI Symptoms. — 4.84 days
Sickle Cell Anemia Crisis
Primary: Cumulative Opioid Dosing — .2; .2 mg/kg
SMA
Primary: Number of Participants Who Achieve Independent Sitting for at Least 10 Seconds — 14 Participants
Osteoarthritis of the Shoulder
Primary: Visual Analogue Scale (VAS: 0-100) for Pain on Movement — 53.7665; 57.7659 units on a scale — p=0.0380
Myasthenic Syndromes, Congenital
Primary: Subject Global Impression (SGI) Score Summary: Mann-Whitney Main Effects Test Results; SGI Score Mixed Model Analysis — -0.13; -1.75; -0.75; -1.14 Scores on a scale…
Sjogren's Syndrome
Primary: Blood Cell Gene Expression — -0.0291486; 0.1330903; 0.2509076; 0.06726222 log 2 fold change — p=0.0000496